Doximity Inc

Rule 10b5-1 Trading Plans

On February 26, 2025, Dr. Regina Benjamin, adirector of the Company, adopted a Rule 10b5-1 trading arrangement for the sale of the Company’s Class A common stock (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Exchange Act Rule 10b5-1(c). Dr. Benjamin’s Rule 10b5-1 Trading Plan, which has a term from February 26, 2025 to May 28, 2026, provides for the potential exercise of vested stock options and the associated sale of up to 65,000 shares of the Company’s Class A common stock in the aggregate pursuant to a series of market orders.

On February 13, 2025, Mr. Tim Cabral, adirector of the Company, adopted a Rule 10b5-1 Trading Plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Cabral’s Rule 10b5-1 Trading Plan, which has a term from February 13, 2025 to May 15, 2026, provides for the potential exercise of vested stock options and the associated sale of up to 120,000 shares of the Company’s Class A common stock in the aggregate and other net vested shares of Class A common stock pursuant to a series of market orders. On the date of the execution of Mr. Cabral’s Rule 10b5-1 Trading

Plan, he held no net vested shares. Mr. Cabral’s net vested share amount will change as additional equity awards vest or shares are subsequently purchased or sold during the term of his Rule 10b5-1 Trading Plan.

On February 12, 2025, Ms. Phoebe Yang, adirector of the Company, terminated a Rule 10b5-1 Trading Plan that she had previously entered into on November 12, 2024. Ms. Yang’s Rule 10b5-1 Trading Plan, which was scheduled to expire pursuant to its terms on September 19, 2025, provided for the sale of 33.33% of net vested shares of Class A common stock pursuant to a series of market orders.

Other than the Rule 10b5-1 Trading Plans noted above, during the quarter ended March 31, 2025, none of our directors or executive officers as defined in Rule 16a-1(f) of the Exchange Actadopted, modified orterminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).